Literature DB >> 11257155

Non-steroidal anti-oestrogens inhibit the differentiation of synovial macrophages into dendritic cells.

J Komi1, M Möttönen, R Luukkainen, O Lassila.   

Abstract

BACKGROUND: Dendritic cells (DC) have been suggested to play an important role in the pathogenesis of rheumatoid arthritis (RA). Agents that inhibit DC differentiation and function may have a therapeutic value in the treatment of RA.
OBJECTIVE: To examine the effect of the non-steroidal anti-oestrogens toremifene and tamoxifen on the differentiation of synovial fluid (SF) macrophages into DC.
METHODS: SF macrophages from patients with RA were cultured with interleukin (IL)-4 and granulocyte/macrophage colony-stimulating factor (GM-CSF) in the presence or absence of anti-oestrogens. The expression of cell surface markers on SF antigen-presenting cells (APC) was studied by flow cytometry. The capacity of SF APC to stimulate allogeneic T cells was studied using the mixed lymphocyte reaction. The production of tumour necrosis factor-alpha, IL-10 and transforming growth factor-beta1 was studied using ELISA.
RESULTS: Anti-oestrogens inhibited the differentiation of SF macrophages into DC and the capacity of SF macrophage-derived DC to stimulate allogeneic T cells.
CONCLUSIONS: By inhibiting the differentiation of SF macrophages into DC, non-steroidal anti-oestrogens may have beneficial effects in RA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257155     DOI: 10.1093/rheumatology/40.2.185

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

Review 1.  Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells.

Authors:  Greg Nalbandian; Susan Kovats
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Regulation of dendritic cell differentiation and function by estrogen receptor ligands.

Authors:  Susan Kovats; Esther Carreras
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

3.  Phenotypic characterization of human decidual macrophages.

Authors:  J Heikkinen; M Möttönen; J Komi; A Alanen; O Lassila
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates.

Authors:  Anna Sapino; Paola Cassoni; Enza Ferrero; Massimo Bongiovanni; Luisella Righi; Nicoletta Fortunati; Pellegrino Crafa; Roberto Chiarle; Gianni Bussolati
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 5.  The effects of tamoxifen on immunity.

Authors:  S Behjati; M H Frank
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 6.  Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity.

Authors:  Susan Kovats
Journal:  Horm Behav       Date:  2012-04-25       Impact factor: 3.587

Review 7.  Androgens in rheumatoid arthritis: when are they effectors?

Authors:  Maurizio Cutolo
Journal:  Arthritis Res Ther       Date:  2009-09-22       Impact factor: 5.156

8.  Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer.

Authors:  A Pinzon-Charry; C S K Ho; T Maxwell; M A McGuckin; C Schmidt; C Furnival; C M Pyke; J A López
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

9.  Using gene expression signatures to identify novel treatment strategies in gulf war illness.

Authors:  Travis J A Craddock; Jeanna M Harvey; Lubov Nathanson; Zachary M Barnes; Nancy G Klimas; Mary Ann Fletcher; Gordon Broderick
Journal:  BMC Med Genomics       Date:  2015-07-09       Impact factor: 3.063

10.  Agonistic activity of tamoxifen, a selective estrogen-receptor modulator (SERM), on arthritic ovariectomized mice.

Authors:  L A S Silva; F B Felix; J M D Araujo; E V Souza; E A Camargo; R Grespan
Journal:  Braz J Med Biol Res       Date:  2017-11-13       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.